Searched for
SYMPTOMS OF CVS
These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsFrom October 2024 till as recently as February 1, 2026, we mostly heard two words on the stock market: Bearish and volatile. The last few d...
These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 38%With most market players back in their offices after the New Year break, volatility is again visible on the street. And there is a possibil...
Flu season is here, and here’s everything Americans need to know about who should get vaccinated, eligibility, safety updates, and where to get flu shotAs respiratory illnesses rise, flu shots are available for most Americans. A small change this year removes thimerosal from all flu vaccine...
Doctors share the cold and flu season must-haves to stock in your cabinet todayCold and flu season comes with discomfort, but being prepared ahead can make recovery manageable. Experts advise stocking up on fever reduc...
She vomited 15 times a day. It took doctors 2 years to diagnose her with rare neuroendocrine illness. What is Cyclic Vomiting Syndrome?Sharisse Zeroonian, a 29-year-old woman, endured years of unexplained vomiting, eventually diagnosed with cyclic vomiting syndrome (CVS). S...
Should you take a career break, sabbatical? Here's advice from 5 people who took job breaks of 6 months to 7 yearsRejoining work after a gap can be challenging. If you are worried about stepping off the corporate ladder out of fear of taking a hit on yo...
CVS removes popular cough and cold medicines from store shelvesCVS has removed popular oral cough and cold medicines like Sudafed, Mucinex, Vicks, Allegra, and Dayquil from its stores. The FDA advisory ...
Nifty healthcare index stocks; Staying bullish on select pharma and hospitalsWhile they clubbed together, the operating matrix of a pharma company making drugs and hospital and a diagnostic company are very different...
New Covid vaccines are on the way as 'Eris' variant risesA new COVID vaccine is due out next month, but health experts and analysts say it is likely to be coolly received even as hospitalizations ...
On a path to recovery; 7 mid-cap pharma stocks with an upside potential up to 47 %After the covid tailwinds got over, pharma stocks witnessed a phase of under-performance. However as the markets get jittery, select pharma...
These 5 midcap stocks with ‘strong buy’ & ‘buy’ ratings can rally over 25%, say analystsFor all those who are busy guessing what will happen to Adani group stocks, there is a market beyond Adani stocks and that is very large. E...
Hyderabad doctor diagnoses woman with vision loss from excessive smartphone usageDr Kumar said that she was referred to him by an eye doctor, in an attempt to rule out neurological causes. He further said that his patien...
Covid pills are here, but they aren't for everyone. Find out if you should take this medicationThe pills have to be started as soon as possible, within five days of the start of symptoms.
WFH woes take over: Most working professionals report eye-strain and vision problemsOffice employees spend at least six hours per day looking at a computer screen.
Watch out for revival of US growth and not Chinese growth: Nandan Chakraborty, Axis CapitalIn a chat with ET Now, Nandan Chakraborty, Axis Capital, says reemergence of US as biggest consumer in the world will help world economy an...
- Prabhudas Picks: IVRCL, L&T, Mundra Port
Prabhudas Lilladher has picked IVRCL, L&T, Mundra Port, Glaxo Smithkline Pharma and Anant Raj Industries.